E sophageal atresia (EA) is a congenital discontinuity of the esophagus that forms upper and lower blind esophageal pouches. Esophageal atresia is commonly associated with congenital tracheoesophageal fistula (TEF), an abnormal connection between the trachea and esophagus. The prevalence of EA, TEF, or both is approximately 1 in 3500 to 5000 live births. 1, 2 In more than 50% of cases, EA/TEF occurs with other anomalies, such as laryngeal cleft and tracheomalacia. 3 The Gross classification describes 5 types of EA/TEF. 4 Type A manifests as EA without TEF, whereas types B, C, D, and H have variable fistula formation. Type B presents as EA with a proximal TEF and a blind distal pouch and accounts for approximately 5% of patients. Types A and B are considered "long gap" EA because there is no distal fistula to elongate the lower esophageal segment by attachment to the airway. Type C is characterized by a blind proximal esophageal pouch and distal TEF to the lower esophagus. This type is the most common, accounting for approximately 85% of EA anomalies. 5 Type D presents with a fistula to the airway from the upper and lower esophageal pouches and occurs in approximately 4% of patients with EA/TEF. Types C and D are generally considered "short gap" because the lower esophagus is usually long enough to attach to the airway. The least common form of TEF is the H-type fistula, which connects the esophagus and trachea (creating the appearance of a capital H) but does not involve EA. An H-type fistula affects between 1% and 4% of patients with EA/TEF. 6, 7 During embryonic development, the trachea and esophagus share a common lumen. Esophageal atresia and TEF result from failed development of the tracheoesophageal septum. Failed fusion and incomplete development of the tracheoesophageal septum may also lead to the formation of a laryngeal cleft. 3 Laryngeal cleft is a rare congenital deficiency of the interarytenoid region of the larynx, tracheoesophageal wall, or both. It is associated with a spectrum of clinical symptoms, ranging from mild stridor to substantial aspiration and recurrent pneumonia. The prevalence of cleft is reported as 1 in 10 000 to 1 in 20 000 live births. 8 Clefts are typically classified using the Benjamin-Inglis system, which designates 4 types. 9 Type I is the least severe and extends to the vocal cords.
Type II extends below the vocal cords but not through the cricoid cartilage. Type III extends though the cricoid into the posterior cervical tracheal membrane, and type IV, the most severe, extends into the thoracic trachea. Types III and IV are associated with severe tracheomalacia. 10 Previous reports in the literature have already established a link between EA/TEF and laryngeal cleft.
11 The objectives of the present study were to assess the prevalence of laryngeal cleft among patients with EA/TEF and to identify whether any types of EA/TEF are linked to a specific type of laryngeal cleft. A secondary objective was to review the age at diagnosis for both conditions and identify factors associated with an early diagnosis.
Methods
The Esophageal Atresia database was used to identify patients who were seen at the Esophageal and Airway Treatment (EAT) Center, a multidisciplinary program composed of physicians from gastroenterology, general surgery, cardiac surgery, anesthesia, otolaryngology, and endocrinology departments at Boston Children's Hospital, Boston, Massachusetts, from August 1, 2009, to August 1, 2016 . This database captures all patients who were seen by a surgeon from the EAT Center for a problem related to the esophagus or airway. The database includes demographic information, such as age and sex, as well as the specific procedures performed by the multidisciplinary EAT team. Patients were included if they were younger than 18 years at the time they were diagnosed with EA and/or TEF and had undergone a procedure or examination by a surgeon from the EAT Center. Patients were excluded if their primary diagnosis was an acquired airway or esophageal trauma (eg, ingestion of a foreign body or caustic ingestion). Data including demographic characteristics, primary diagnoses, dates of diagnosis, comorbidities, and airway/ esophageal surgical interventions were collected and analyzed. This study was approved by the Institutional Review Board at Boston Children's Hospital, which waived the need for patient consent. The χ 2 test was used to compare the distribution of types of laryngeal cleft by types of EA/TEF. In addition, we evaluated the age at which patients were diagnosed with each condition and whether their place of residence affected the timing of their diagnosis. To compare the timing of diagnosis by residence, we used the Wilcoxon rank sum test. All statistical analyses were performed using SAS, version 9.4 (SAS Institute Inc).
Results
Three hundred fifty-three patients were seen at the EAT Center between August 1, 2009, and August 1, 2016. Of these, 7 patients were diagnosed with acquired esophageal and/or airway conditions other than congenital anomalies and were therefore excluded from this study. An additional 76 patients did not have a diagnosis of EA/TEF and were also excluded. The remaining 270 patients with a diagnosis of congenital EA, TEF, or both were included in the data
Key Points
Question What is the association between esophageal atresia/tracheoesophageal fistula and laryngeal cleft, and are there significant associations by type?
Findings In this analysis of 270 patients diagnosed with esophageal atresia/tracheoesophageal fistula, laryngeal cleft was diagnosed in 53 (19.6%), and there was no difference in the distribution of types of laryngeal cleft by type of esophageal atresia/tracheoesophageal fistula.
Meaning Because children with esophageal atresia/ tracheoesophageal fistula have a much higher prevalence of laryngeal cleft than the general population, multidisciplinary esophageal and airway programs serve as an ideal clinical setting for treatment of these patients. 
Prevalence of Cleft Among Types of EA/TEF
We found no meaningful difference in the distribution of types of laryngeal cleft by type of EA/TEF ( Table 2) . Among 16 patients with EA/TEF type A or B, 9 (56%) had a type I cleft, 6 (38%) had a type II cleft, and 1 (6%) had a type III cleft. Among 35 patients with EA/TEF type C or D, 20 (57%) had a type I cleft, 11 (31%) had a type II cleft, and 3 (9%) had a type III cleft. Of the 2 patients with an H-type fistula, 1 (50%) had a type I cleft and 1 (50%) had a type II cleft.
Timing of Diagnosis
The data set was analyzed to determine when patients were first diagnosed with EA/TEF or laryngeal cleft and the period that lapsed until a secondary diagnosis was made. Forty-one of 53 patients (77%) were diagnosed on the same day or within 7 days. On one occasion, the diagnosis of laryngeal cleft was made 1 day before the diagnosis of type C EA/TEF. In all other instances, laryngeal cleft was diagnosed after EA/TEF or at the same time. Owing to the high prevalence of comorbid laryngeal cleft and EA/TEF, most patients underwent airway endoscopy to diagnose any additional conditions at the time of EA/TEF repair. All remaining patients underwent airway endoscopy at a time other than EA/TEF repair.
A significant difference was identified between patients who resided outside Massachusetts and patients who lived in Massachusetts, where our institution is located. Out-of-state patients were more likely to be diagnosed with EA/TEF at an older age than in-state patients (mean difference, 1.5 years; 95% CI, 0-2.9 years).
Discussion
Congenital EA and TEF are rare defects that typically cause symptoms of aspiration, choking, coughing after feeding, cyanosis, and potentially life-threatening complications. 12 In most cases, EA/TEF is diagnosed in infancy, at which time other congenital abnormalities may also be diagnosed. 13 Laryngeal cleft is a commonly reported comorbidity, likely because laryngeal cleft and EA/TEF have similar embryonic origins. However, much of the literature regarding the association between these 2 conditions is in the form of case reports or small case series. 2, [14] [15] [16] [17] [18] [19] [20] [21] To our knowledge, the present study includes the largest number of patients with both EA/TEF and laryngeal cleft reported in the literature to date. Of 270 patients with EA/TEF, 53 (19.6%) had a comorbidity of laryngeal cleft. This rate is considerably higher than the The EA/TEF type was based on the Gross classification. 4 prevalence of laryngeal cleft in the general population (0.01%-0.005%), and this difference merits clinical attention. 22 A recent study asserted that laryngeal cleft should be suspected in any child with a history of EA/TEF repair who presents with recurrent aspiration. 11 Microlaryngoscopy and bronchoscopy under general anesthesia by an experienced otolaryngologist is the criterion standard for evaluation. 10 In addition, a modified barium swallow study may be performed to evaluate for aspiration and swallowing dysfunction. Overall, prompt diagnosis and management of laryngeal cleft is necessary to reduce risk for pulmonary injury. Analyzing the distribution of laryngeal cleft types among patients with EA/TEF did not yield any significant associations. As in the general population, laryngeal cleft types I and II were the most common in the patient sample, and there were no significant links to any EA/TEF types. Dates of diagnosis for laryngeal cleft and EA/TEF were also analyzed, which demonstrated that 77% of patients were diagnosed with both conditions on the same day or within 7 days. However, when patients were grouped based on their place of residence, outof-state patients were significantly more likely to be diagnosed with EA/TEF at an older age than in-state patients.
Controversy surrounds the need for further diagnostic testing before EA/TEF repair. A survey of the International Pediatric Endosurgery Group in 2013 reviewed current practice patterns in EA/TEF repair. 23 The survey found that preoperative bronchoscopy was routinely performed by roughly 60% of 170 respondents. However, in a retrospective review of 88 patients, Sharma and Srinivas 24 found that 20.5% of patients who underwent a preoperative bronchoscopy had additional clinical findings, including TEF and laryngotracheal cleft. These authors concluded that laryngotracheobronchoscopy should be performed before definitive surgical procedures. However, it is important to consider the detrimental effects of multiple exposures to anesthesia in pediatric patients, especially in infants as young as those in the present study. For this reason, it is common practice for the multidisciplinary team at our institution to perform laryngotracheobronchoscopy immediately before surgery, within the same episode of anesthesia. This procedure allows for thorough preoperative evaluation without incurring the risks of additional sedation.
Limitations
The primary limitations of this study include the retrospective design and the absence of complete diagnostic testing in the patient sample. More specifically, not all patients were referred to the otolaryngology department for a thorough airway assessment. Therefore, the number of patients described as having laryngeal cleft in this sample may be a conservative estimate. Future studies should include direct laryngoscopy and bronchoscopy to identify or rule out a diagnosis of laryngeal cleft before initial repair of EA/TEF.
Conclusions
Pediatric patients with EA/TEF have a greatly increased prevalence of laryngeal cleft compared with the general population. Protocols should be adopted to routinely assess patients with EA/TEF for laryngeal cleft and other upper airway anomalies. As previously reported, multidisciplinary esophageal and airway programs serve as an ideal clinical setting for management of EA/TEF. Preoperative upper airway evaluation may facilitate diagnosis of laryngeal cleft and other anomalies, preventing health complications and obviating the need for further medical attention later in the child's life.
